The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXIII. Baseline predictors of vascular events
Abstract
Objective: To determine the baseline (time 0) risk factors associated with the subsequent occurrence of vascular events in a multiethnic US cohort (LUMINA [LUpus in MInorities: NAture versus nurture]) of patients with systemic lupus erythematosus (SLE). Methods: Five hundred forty‐six LUMINA patients were assessed at time 0 for traditional and nontraditional (disease‐related) risk factors for vascular events. These were defined as 1) cardiovascular (myocardial infarction and/or definite or classic angina and/or the undergoing of a vascular procedure for myocardial infarction [coronary artery bypass graft]), 2) cerebrovascular (stroke), and 3) peripheral vascular (arterial claudication and/or gangrene or significant tissue loss and/or arterial thrombosis in peripheral arteries). The observation time (followup time in the cohort) was the interval between time 0 and the last visit. The unit of analysis was the patient and not each vascular event. Variables at time 0 and vascular events were examined by univariable and multivariable (logistic and Cox proportional hazards regression) analyses. Age, sex, ethnicity, followup time, and all known risk factors for the occurrence of vascular events were included in the model. Results: Thirty‐four patients (6.2%) developed one or more vascular event after time 0. The overall median duration of followup in the cohort was 73.8 months (range 10.8–111.3 months). Vascular events (13 cardiovascular, 18 cerebrovascular, 5 peripheral vascular) occurred in 7 Hispanics from Texas (6.5%), 1 Hispanic from Puerto Rico (1.2%), 15 African Americans (7.5%), and 11 Caucasians (7.1%). The mean total number of traditional risk factors was significantly higher in patients who developed vascular events than in those who did not (7.1 versus 5.6). Independent predictors of vascular events were older age, current smoking status, longer followup time, elevated serum levels of C‐reactive protein (CRP), and the presence of any antiphospholipid antibody. The same variables were identified when time‐dependent analyses were performed, although azathioprine use was also found to be a contributing factor. Conclusion: Smoking, previously not reported in SLE, emerged as a predictor of vascular events and should be strongly discouraged. Antiphospholipid antibodies and CRP support the role of inflammation and autoimmunity in the development of accelerated atherosclerosis in SLE. Ethnicity was not associated with vascular events in our patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
Hochberg, M. C. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400928 · Cited by 11,409
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
Measuring the Functional Components of Social Support
Cohen, S., Mermelstein, R., Kamarck, T., & Hoberman, H. M. (1985) · Social Support: Theory, Research and Applications · doi:10.1007/978-94-009-5115-0_5 · Cited by 2,296
Socioeconomic factors and cardiovascular disease: a review of the literature.
Kaplan, G. A., & Keil, J. E. (1993) · Circulation · doi:10.1161/01.cir.88.4.1973 · Cited by 1,845
Manzi, S., Meilahn, E. N., Rairie, J. E., Conte, C. G., Medsger, T. A., Jansen-McWilliams, L., D'Agostino, R. B., & Kuller, L. H. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009122 · Cited by 1,834
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B.-A., Davis, A., Lockshin, M. D., Sammaritano, L., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,427
Brandt, J. T., Triplett, D. A., Alving, B. M., & Scharrer, I. (1995) · PubMed · Cited by 1,164
The bimodal mortality pattern of systemic lupus erythematosus
Urowitz, M. B., Bookman, A. A. M., Koehler, B. E., Gordon, D. A., Smythe, H. A., & Ogryzlo, M. A. (1976) · The American Journal of Medicine · doi:10.1016/0002-9343(76)90431-9 · Cited by 1,000
Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus
Asanuma, Y., Oeser, A., Shintani, A. K., Turner, E., Olsen, N., Fazio, S., Linton, M. F., Raggi, P., & Stein, C. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035611 · Cited by 892
Liang, M. H., Socher, S. A., Larson, M. G., & Schur, P. H. (1989) · Arthritis & Rheumatism · doi:10.1002/anr.1780320909 · Cited by 789
Gladman, D. D., Urowitz, M. B., Goldsmith, C. H., Fortin, P., Ginzler, E., Gordon, C., Hanly, J. G., Isenberg, D. A., Kalunian, K., Nived, O., et al. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400506 · Cited by 759
Freeman, D. J., Norrie, J., Caslake, M. J., Gaw, A., Ford, I., Lowe, G. D. O., O’Reilly, D. S. J., Packard, C. J., Sattar, N., & for the West of Scotland Coronary Prevention Study Group (2002) · Diabetes · doi:10.2337/diabetes.51.5.1596 · Cited by 728
Self-citationRisk factors for coronary artery disease in patients with systemic lupus erythematosus
Petri, M., Perez-Gutthann, S., Spence, D., & Hochberg, M. C. (1992) · The American Journal of Medicine · doi:10.1016/0002-9343(92)90578-y · Cited by 624
Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus
Manzi, S., Selzer, F., Sutton-Tyrrell, K., Fitzgerald, S. G., Rairie, J. E., Tracy, R. P., & Kuller, L. H. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199901)42:1<51::aid-anr7>3.0.co;2-d · Cited by 559
Risk Factors for Cardiovascular Disease in Systemic Lupus Erythematosus
Svenungsson, E., Jensen-Urstad, K., Heimbürger, M., Silveira, A., Hamsten, A., de Faire, U., Witztum, J. L., & Frostegård, J. (2001) · Circulation · doi:10.1161/hc4101.097518 · Cited by 500
Harris, E. N. (1990) · American Journal of Clinical Pathology · doi:10.1093/ajcp/94.4.476 · Cited by 414
Doria, A., Shoenfeld, Y., Wu, R., Gambari, P. F., Puato, M., Ghirardello, A., Gilburd, B., Corbanese, S., Patnaik, M., Zampieri, S., et al. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.11.1071 · Cited by 403
Self-citationBruce, I. N., Urowitz, M. B., Gladman, D. D., Ibañez, D., & Steiner, G. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11296 · Cited by 394
Kalinowski, L., Dobrucki, I. T., & Malinski, T. (2004) · Circulation · doi:10.1161/01.cir.0000129087.81352.7a · Cited by 326
Alarc�n, G. S., McGwin, Jr., Bastian, H. M., Roseman, J., Lisse, J., Fessler, B. J., Friedman, A. W., Reveille, J. D., & LUMINA Study Group (2001) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200104)45:2<191::aid-anr173>3.0.co;2-2 · Cited by 325
Self-citationPetri, M., Lakatta, C., Magder, L., & Goldman, D. (1994) · The American Journal of Medicine · doi:10.1016/0002-9343(94)90151-1 · Cited by 323
Alarcón, G. S., Friedman, A. W., Straaton, K. V., Moulds, J. M., Lisse, J., Bastian, H. M., McGwin, G., Bartolucci, A. A., Roseman, J. M., & Reveille, J. D. (1999) · Lupus · doi:10.1191/096120399678847704 · Cited by 309
Self-citationBorba, E., & Bonfá, E. (1997) · Lupus · doi:10.1177/096120339700600610 · Cited by 289
Ridker, P. M. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(03)00774-4 · Cited by 260
C-reactive protein and cardiovascular disease: new insights from an old molecule
Hirschfield, G. M., & Pepys, M. B. (2003) · QJM: An International Journal of Medicine · doi:10.1093/qjmed/hcg134 · Cited by 251
Reveille, J. D., Moulds, J. M., Ahn, C. W., Friedman, A., Baethge, B. A., Roseman, J. M., Straaton, K. V., Alarc�n, G. S., & the Lumina Study Group (1998) · Arthritis & Rheumatism · Cited by 244
Self-citationSelzer, F., Sutton‐Tyrrell, K., Fitzgerald, S. G., Pratt, J. E., Tracy, R. P., Kuller, L. H., & Manzi, S. (2004) · Arthritis & Rheumatism · doi:10.1002/art.11418 · Cited by 229
Alarc�n, G. S., Roseman, J. M., Bartolucci, A. A., Friedman, A., Moulds, J. M., Goel, N., Straaton, K. V., Reveille, J. D., & the Lumina Study Group (1998) · Arthritis & Rheumatism · Cited by 206
Self-citationDelgado Alves, J., Ames, P. R. J., Donohue, S., Stanyer, L., Noorouz‐Zadeh, J., Ravirajan, C., & Isenberg, D. A. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10542 · Cited by 199
Cardiovascular Manifestations in Systemic Lupus Erythematosus. Prospective Study of 100 Patients
Badui, E., Garcia-Rubi, D., Robles, E., Jimenez, J., Juan, L., Deleze, M., Diaz, A., & Mintz, G. (1985) · Angiology · doi:10.1177/000331978503600705 · Cited by 182
Wajed, J. (2004) · Rheumatology · doi:10.1093/rheumatology/keg436 · Cited by 169
George, J., Harats, D., Gilburd, B., Afek, A., Shaish, A., Kopolovic, J., & Shoenfeld, Y. (2000) · Circulation · doi:10.1161/01.cir.102.15.1822 · Cited by 167
Self-citationSvenungsson, E., Gunnarsson, I., Fei, G., Lundberg, I. E., Klareskog, L., & Frostegård, J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11264 · Cited by 164
Factors associated with coronary artery calcification in young female patients with SLE
Manger, K., Kusus, M., Forster, C., Ropers, D., Daniel, W. G., Kalden, J. R., Achenbach, S., & Manger, B. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.62.9.846 · Cited by 155
Socioeconomic Status and Carotid Atherosclerosis
Lynch, J. W., Kaplan, G. A., Salonen, R. M., Cohen, R. D., & Salonen, J. T. (1995) · Circulation · doi:10.1161/01.cir.92.7.1786 · Cited by 142
Systemic Lupus Erythematosus and Accelerated Atherosclerosis
Hahn, B. H. (2003) · New England Journal of Medicine · doi:10.1056/nejmp038168 · Cited by 132
A Hexagonal (II) Phase Phospholipid Neutralization Assay for Lupus Anticoagulant Identification
Triplett, D. A., Barna, L. K., & Unger, G. A. (1993) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649671 · Cited by 128
Social inequality, ethnicity and cardiovascular disease
Cooper, R. (2001) · International Journal of Epidemiology · doi:10.1093/ije/30.suppl_1.s48 · Cited by 119
Boumpas, D. T., Barez, S., Klippel, J. H., & Balow, J. E. (1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-112-9-674 · Cited by 118
Rahman, P., Mb, U., Gladman, D. D., Bruce, I. N., & Genest, J. J. (1999) · PubMed · Cited by 117
Roman, M. J., Salmon, J. E., Sobel, R. E., Lockshin, M. D., Sammaritano, L. R., Schwartz, J. E., & Devereux, R. B. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01453-3 · Cited by 112
Pepys, M. B., Lanham, J., & de Beer, F. C. (1982) · Clinics in Rheumatic Diseases · doi:10.1016/s0307-742x(21)00201-0 · Cited by 109
Wu, R., & Lefvert, A. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb06652.x · Cited by 94
Self-citationNuttall, S. L., Heaton, S., Piper, M. K., Martin, U., & Gordon, C. (2003) · British journal of rheumatology · doi:10.1093/rheumatology/keg212 · Cited by 93
Engle, E. W., Callahan, L. F., Pincus, T., & Hochberg, M. C. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330220 · Cited by 86
Pilowsky, I. (1993) · Journal of Psychosomatic Research · doi:10.1016/0022-3999(93)90123-w · Cited by 71
Vascular events in hypertensive patients with systemic lupus erythematosus
Rahman, P., Agüero, S., Gladman, D. D., Hallett, D. C., & Urowitz, M. B. (2000) · Lupus · doi:10.1191/096120300669204787 · Cited by 60
Atheroma: links with antiphospholipid antibodies, Hughes syndrome and lupus
Harats, D., George, J., Levy, Y., Khamashta, M. A., Hughes, G. R., & Shoenfeld, Y. (1999) · QJM · doi:10.1093/qjmed/92.1.57 · Cited by 46
Self-citationCakir, B., HEISS, G. M., Pankow, J. S., Salomaa, V. V., Sharrett, A. R., Couper, D. J., & Weston, B. W. (2003) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2003.01263.x · Cited by 22
Cardiovascular Morbidity in the Hopkins Lupus Cohort
Petri, M. (2001) · Elsevier eBooks · doi:10.1016/b978-044450669-6/50028-1 · Cited by 6
Ho (2001) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200110)44:10 · Cited by 3
Cited by
Kaul, A., Gordon, C., Crow, M. K., Touma, Z., Urowitz, M. B., van Vollenhoven, R., Ruiz-Irastorza, G., & Hughes, G. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.39 · Cited by 1,391
Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P., & Khamashta, M. A. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.101766 · Cited by 978
Understanding the Epidemiology and Progression of Systemic Lupus Erythematosus
Pons-Estel, G. J., Alarcón, G. S., Scofield, L., Reinlib, L., & Cooper, G. S. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.10.007 · Cited by 908
Self-citationAdolescents with a chronic condition: challenges living, challenges treating
Sawyer, S. M., Drew, S., Yeo, M. S., & Britto, M. T. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60370-5 · Cited by 656
Oxidized LDL: Diversity, Patterns of Recognition, and Pathophysiology
Levitan, I., Volkov, S., & Subbaiah, P. V. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2733 · Cited by 473
Metadata
- Authors
- Toloza, S. M. A., Uribe, A. G., McGwin, G., Alarcón, G. S., Fessler, B. J., Bastian, H. M., Vilá, L. M., Wu, R., Shoenfeld, Y., Roseman, J. M., Reveille, J. D., & for the LUMINA Study Group
- Venue
- Arthritis & Rheumatism
- Publisher
- Wiley
- Published
- 2004-12
- Volume
- 50
- Issue
- 12
- Pages
- 3947-3957
- ISSN
- 0004-3591 (ISSN-L)
- 1529-0131
- OpenAlex
- W2010633868
- Cited by
- 319
- References
- 54
- FWCI
- 9.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.